» Articles » PMID: 12427754

Phosphorylation and Hsp90 Binding Mediate Heat Shock Stabilization of P53

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2002 Nov 13
PMID 12427754
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

The p53 tumor suppressor is stabilized and activated by diverse stress signals. In this study, we investigated the mechanism of p53 activation by heat shock. We found that heat shock inhibited p53 ubiquitination and caused accumulation of p53 at the post-transcriptional level. Heat shock induced phosphorylation of p53 at serine 15 in an ATM kinase-dependent fashion, which may contribute partially to heat-induced p53 accumulation. However, p53 accumulation also occurred after heat shock in ATM-deficient cells. Heat shock induced conformational change of wild type p53 and binding to hsp90. Inhibition of hsp90-p53 interaction by geldanamycin prevented p53 accumulation partially in ATM-wild type cells and completely in ATM-deficient cells. Therefore, phosphorylation and interaction with hsp90 both contribute to stabilization of p53 after heat shock.

Citing Articles

From regulation to deregulation of p53 in hematologic malignancies: implications for diagnosis, prognosis and therapy.

Ahmadi S, Rahimian E, Rahimi S, Zarandi B, Bahraini M, Soleymani M Biomark Res. 2024; 12(1):137.

PMID: 39538363 PMC: 11565275. DOI: 10.1186/s40364-024-00676-9.


Detecting Posttranslational Modifications of Hsp90 Isoforms.

Sager R, Backe S, Neckers L, Woodford M, Mollapour M Methods Mol Biol. 2023; 2693:125-139.

PMID: 37540432 PMC: 10518168. DOI: 10.1007/978-1-0716-3342-7_11.


HSP90β prevents aging-related cataract formation through regulation of the charged multivesicular body protein (CHMP4B) and p53.

Fu J, Zheng S, Wang Y, Hu X, Xiao Y, Wang J Proc Natl Acad Sci U S A. 2023; 120(31):e2221522120.

PMID: 37487085 PMC: 10400967. DOI: 10.1073/pnas.2221522120.


TP53 in Biology and Treatment of Osteosarcoma.

Synoradzki K, Bartnik E, Czarnecka A, Fiedorowicz M, Firlej W, Brodziak A Cancers (Basel). 2021; 13(17).

PMID: 34503094 PMC: 8428337. DOI: 10.3390/cancers13174284.


Structural and Drug Targeting Insights on Mutant p53.

Gomes A, Ramos H, Inga A, Sousa E, Saraiva L Cancers (Basel). 2021; 13(13).

PMID: 34283062 PMC: 8268744. DOI: 10.3390/cancers13133344.